Literature DB >> 1394776

Rabies in China: recommendations for control.

A Kureishi1, L Z Xu, H Wu, H G Stiver.   

Abstract

Reviewed are the results of 15 years' experience with rabies at You-An Infectious Disease Hospital, Beijing, China. The purpose of the study was to determine whether there are any epidemiological or clinical features of rabies that are unique to China and which might be important in developing a strategy to control it. During the period under study, 64 patients with rabies were admitted to You-An Hospital. Exposure to dogs was associated with 61 cases, two involving the handling of dog carcasses that were being prepared for meals. All of the exposures occurred in rural areas, and none of the patients received adequate prophylaxis. Patients with proximal sites of exposure and with severe injuries developed rabies after short incubation periods (P less than 0.05, and P less than 0.02, respectively). Failed vaccination was also associated with a short incubation period (P less than 0.05). Haematemesis occurred in 20 patients and was associated with shorter incubation periods (P less than 0.02), facial exposure sites (P = 0.021), and severe injuries (P = 0.047). A strategy to control rabies in China should include efforts to educate the public about handling the carcasses of stray dogs, in addition to the currently recommended strategy of controlling the dog population and of vaccinating domesticated animals.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1394776      PMCID: PMC2393387     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  12 in total

1.  Human rabies transmitted by the bite of a bat: with comments on the duck-embryo vaccine.

Authors:  J R KENT; S M FINEGOLD
Journal:  N Engl J Med       Date:  1960-11-24       Impact factor: 91.245

2.  Rabies in man handling infected calf.

Authors:  W U Tariq; M S Shafi; S Jamal; M Ahmad
Journal:  Lancet       Date:  1991-05-18       Impact factor: 79.321

3.  History of rabies: advances in research towards rabies prevention during the last 30 years.

Authors:  P Sureau
Journal:  Rev Infect Dis       Date:  1988 Nov-Dec

Review 4.  Rabies in the Americas and remarks on global aspects.

Authors:  J H Steele
Journal:  Rev Infect Dis       Date:  1988 Nov-Dec

5.  Program for the elimination of urban rabies in Latin America.

Authors:  E Escobar Cifuentes
Journal:  Rev Infect Dis       Date:  1988 Nov-Dec

6.  Human rabies in the United States, 1960 to 1979: epidemiology, diagnosis, and prevention.

Authors:  L J Anderson; K G Nicholson; R V Tauxe; W G Winkler
Journal:  Ann Intern Med       Date:  1984-05       Impact factor: 25.391

7.  Rabies control in the Republic of the Philippines: benefits and costs of elimination.

Authors:  D B Fishbein; N J Miranda; P Merrill; R A Camba; M Meltzer; E T Carlos; C F Bautista; P V Sopungco; L C Mangahas; L M Hernandez
Journal:  Vaccine       Date:  1991-08       Impact factor: 3.641

8.  Unexplained rabies in three immigrants in the United States. A virologic investigation.

Authors:  J S Smith; D B Fishbein; C E Rupprecht; K Clark
Journal:  N Engl J Med       Date:  1991-01-24       Impact factor: 91.245

Review 9.  Rabies in Thailand: 1990.

Authors:  H Wilde; S Chutivongse; W Tepsumethanon; P Choomkasien; C Polsuwan; B Lumbertdacha
Journal:  Rev Infect Dis       Date:  1991 Jul-Aug

10.  Use of serum and vaccine in combination for prophylaxis following exposure to rabies.

Authors:  F T Lin; S B Chen; Y Z Wang; C Z Sun; F Z Zeng; G F Wang
Journal:  Rev Infect Dis       Date:  1988 Nov-Dec
View more
  14 in total

1.  Update on rabies diagnosis and treatment.

Authors:  Alan C Jackson
Journal:  Curr Infect Dis Rep       Date:  2009-07       Impact factor: 3.725

2.  A new immunostimulatory complex (PICKCa) in experimental rabies: antiviral and adjuvant effects.

Authors:  H X Lin; C Gontier; M F Saron; P Perrin
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

3.  Survey of fox trappers in northern Alaska for rabies antibody.

Authors:  E H Follmann; D G Ritter; M Beller
Journal:  Epidemiol Infect       Date:  1994-08       Impact factor: 2.451

Review 4.  Status of antiviral therapeutics against rabies virus and related emerging lyssaviruses.

Authors:  Venice Du Pont; Richard K Plemper; Matthias J Schnell
Journal:  Curr Opin Virol       Date:  2019-02-10       Impact factor: 7.090

5.  Human rabies: a descriptive observation of 21 children in Kinshasa, the Democratic Republic of Congo.

Authors:  Delphin I Muyila; Michel N Aloni; Marie Josée Lose-Ekanga; Jules M Nzita; Alexandre Kalala-Mbikay; Henri L Bongo; Mathilde N Esako; Jean Pierre Malonga-Biapi; BenoÎt Mputu-Dibwe; Muriel L Aloni; Mathilde B Ekila
Journal:  Pathog Glob Health       Date:  2014-10       Impact factor: 2.894

6.  Analysis of rabies in China: transmission dynamics and control.

Authors:  Juan Zhang; Zhen Jin; Gui-Quan Sun; Tao Zhou; Shigui Ruan
Journal:  PLoS One       Date:  2011-07-14       Impact factor: 3.240

7.  Antemortem diagnosis and prevention of human rabies.

Authors:  Shampur Narayana Madhusudana; Suja Moorlyath Sukumaran
Journal:  Ann Indian Acad Neurol       Date:  2008-01       Impact factor: 1.383

8.  Using serology to assist with complicated post-exposure prophylaxis for rabies and Australian bat lyssavirus.

Authors:  Niall Conroy; Susan Vlack; Julian M Williams; John J Patten; Robert L Horvath; Stephen B Lambert
Journal:  PLoS Negl Trop Dis       Date:  2013-02-28

9.  Furious rabies after an atypical exposure.

Authors:  Heiman F L Wertheim; Thai Q Nguyen; Kieu Anh T Nguyen; Menno D de Jong; Walter R J Taylor; Tan V Le; Ha H Nguyen; Hanh T H Nguyen; Jeremy Farrar; Peter Horby; Hien D Nguyen
Journal:  PLoS Med       Date:  2009-03-17       Impact factor: 11.069

10.  A multi-site study on knowledge, attitudes, beliefs and practice of child-dog interactions in rural China.

Authors:  Jiabin Shen; Shaohua Li; Huiyun Xiang; Shulan Pang; Guozhang Xu; David C Schwebel
Journal:  Int J Environ Res Public Health       Date:  2013-03-07       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.